Yarley
-
Paratek Pharmaceuticals Acquires Yardley-Based Optinose in $330M Deal
Paratek Pharmaceuticals of Boston has entered into a definitive agreement to buy Yardley-based Optinose in a deal worth up to $330 million, writes John George…
Founding Partners
Advertisement
Affiliate Partners
